4//SEC Filing
Naeve Gregory S. 4
Accession 0001358403-18-000074
CIK 0001358403other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:03 PM ET
Size
5.5 KB
Accession
0001358403-18-000074
Insider Transaction Report
Form 4
Naeve Gregory S.
Sr. VP, Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2018-07-02+34,125→ 34,125 totalExercise: $7.72Exp: 2028-07-01→ Common Stock (34,125 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001714833
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:03 PM ET
- Size
- 5.5 KB